Scholars Central

Conference abstractPublished 13 Mar 2017

Lipid-based pharmaceutical formulations for patient-centric product development

Authors: Sharareh Salar-Behzadi

Research Center Pharmaceutical Engineering GmbH, Austria

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Lipids and lipid-based excipients are increasingly applied for development of patient-centric products. Their application in the pharmaceutical formulations covers a wide range, from taste-masking of oral dosage forms with modified; both immediate- and extended release profile to development of advanced nanoparticles for pulmonary or parenteral route of drug administration. Despite of this diversity in application, the drug release instability and the lack of mechanistic understanding of it still prevent the larger-scale application of lipidic excipients. This abstract provides a comprehensive overview on the complex solid state behavior of lipids and describes methods for monitoring this behavior for obtaining reliable and reproducible dosage forms. Methodology & Theoretical Orientation: Solid state behavior of lipids was studied as the response to the composition of formulation and to the critical parameters of the applied product manufacturing process, using X-ray diffraction, PLM and DSC. The applied processes were hot-melt coating for taste-masking and high pressure homogenization for preparation of nanosuspensions. Quality by Design (QbD) tools were used for monitoring the manufacturing process. Findings: The instability of lipidic formulations can be addressed to both changes in molecular and supra-molecular levels. Changes in molecular level mainly contains polymorphic transformation and alteration in crystallite thickness, which can be monitored by careful selection of formulation composition and process parameters. Certain surfactants can be used as modifier, influencing the kinetic character of polymorphic transition of lipids. Process temperature can be monitored to control both crystallite growth kinetics and polymorphic transition. Understanding the microphase separation of formulations containing emulsifier is necessary and will help to improve the selection of pharmaceutical formulations.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sharareh Salar-Behzadi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels